Endovascular Treatment of Peripheral Artery Disease

Inclusion Criteria: 1. Patient must sign the informed consent form prior to the index-procedure. 2. Patient is older than 18 years. 3. Patient is compliant with the requested follow-up visits at week 6 and month 12 and the treatment regime. 4. Patient suffers from intermittent claudication (Rutherford 2-3) or critical limb ischemia (Rutherford 4-5). 5. Target lesion is an occlusion or diameter stenosis is ≥70% by visual estimate. 6. Target lesion is located in the common and external iliac artery, in the common and superficial femoral artery, popliteal artery and/or the below-the-knee (BTK) arteries (anterior tibial artery, posterior tibial artery or peroneal artery) . Exclusion Criteria: 1. Patients with Rutherford 0, 1 and 6. 2. Patient is pregnant. 3. Patients with serum creatinine \>2.0 mg/dL or renal dialysis. 4. Patient has an acute thrombus or aneurysm in the target arteries. 5. Patient has a life expectancy of \<12 months. 6. Patient with bypass that involves the target arteries. 7. Patient has a target lesion that cannot be crossed with a guidewire. 8. Patient suffers from acute limb ischemia defined as any sudden decrease in limb perfusion causing a potential threat to limb viability. 9. Patient has scheduled elective non-vascular procedures within 3 months after index-procedure. Vascular procedures are allowed within 3 months after the index-procedure if it is guaranteed that acetylic salicylic acid and clopidogrel intake is not interrupted. 10. Contraindication for anti-thrombotic therapy (coagulopathy, …). 11. Patient has a known intolerance to anti-thrombotic medication or contrast agents.